Colorectal Cancer clinical trials
Showing 451–500 of 533 active trials. Describe your situation to see which ones you may be eligible for.
- Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
- Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
- Better Options for Chronic Cancer Pain
- HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
- Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
- ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
- Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
- Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- TLR9 Immunotherapy for Peritoneal Carcinomatosis
- A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
- Feasibility Study for Repurposing RET Inhibitors
- Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
- NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies
- Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
- Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
- S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas
- Animated Storytelling to Promote Colorectal Cancer Screening
- Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas
- Life Expectancy-informed Colorectal Cancer Screening
- Preventing Early-Onset Colorectal Cancer in the VA
- Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
- Implementation Intention Planning Guide for FIT Colon Cancer Screening
- Improving Rates of Diagnostic Colonoscopy in Native Americans
- Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer
- A Study Testing SOT109 for the First Time in Patients, to Assess How Safe SOT109 is, How Well it Works, and How the Body Handles it in Patients With Advanced Colorectal Cancer That Can Not be Removed by Surgery or is Metastatic
- Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors
- Decision Counseling and Follow-up for Shield+ Patients
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
- A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
- The Canopy Cancer Collective Clinical Registry Protocol
- Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
- Use of GI Genius™ XR Software in Virtual Reality Headset During Routine Colonoscopy
- Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
- SAMe in Prevention of Oxaliplatin-associated Liver Injury
- Colorectal Cancer Screening in the Homeless
- The PharmFIT Study
- Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)
- Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)
- Facilitators and Barriers to Cancer Treatment Among Texas Residents
- NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
- Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
- Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
- Rural Indiana Screening for Colorectal Cancer
- Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
- AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening Uptake
- SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study
- Head to Head Trial of Mailed Cologuard to Mailed FIT
- Large-Scale Implementation of a Decision Aid About Colorectal Cancer Screening
- Patient Navigation for Colorectal Cancer Screening
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.